Fundraising FoxSHC Therapeutics
1 known investors
Find your way into SHC Therapeutics
Sign up to see every warm intro you have to SHC Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SHC Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SHC Therapeutics is a pre-clinical biopharmaceutical company developing bio-therapeutics using its proprietary Genomic RNA Packaging Enhancement (GRPE) platform to deliver targeted therapies. It aims to create personalized and precision treatments across a range of disease areas, with a lead candidate in the pre-clinical phase.
Investors · 1
Frequently asked questions
- What does SHC Therapeutics do?
- SHC Therapeutics is a pre-clinical biopharmaceutical company developing bio-therapeutics using its proprietary Genomic RNA Packaging Enhancement (GRPE) platform to deliver targeted therapies. It aims to create personalized and precision treatments across a range of disease areas, with a lead candidate in the pre-clinical phase.
- Who are SHC Therapeutics's investors?
- SHC Therapeutics's investors include CWRU Technology Ventures.